维普中文期刊产品整合服务
9篇 您的检索式:作者名="yon Moos R"
    题名 作者 年代 出处 被引量
1Delaying skel- etal-related events in a randomized Phase III study of de- nosumab versus zoledronic acid in patients with ad- vanced cancer显示文摘Henry DH yon Moos R Hungria V 2010J Clin Oncol2010,28,15:1
2First-line temo- zolomide combined with bevacizumab in metastatic melanoma:a muhicentre phase II trial (SAKK50/07) 显示文摘yon Moos R Seifert B Simcock M 2012Ann Oncol2012,23,2:1
3Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primal breast cancer 显示文摘Furstenberger G yon Moos R Lucas R 2006Br J Cancer2006,94,4:1
4First-line temozolomide combined with bevacizumab in metastatic melanoma:a multicen- tre phase II trial (SAKK 50/07)显示文摘yon Moos R Seifert B Simcock M 2012Ann Oncol2012,23,2:1
5Phase I1 studyof capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer 显示文摘Koeberle D Burkhard R yon Moos R 2008Br J Cancer2008,98,:1
6Phase Ⅱ study of eapecit abine and oxaliplatin given prior to and concurrently with preopera rive pelvic radiotherapy in patients with locally advanced rectal cancer显示文摘Koeberle D Burkhard R R yon Moos 2008British Journal of Cancer2008,98,:1
7First-line temo- zolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07) 显示文摘yon Moos R Seifert B Simcock M 2012Ann Oncol2012,23,2:1
8Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts 显示文摘yon Moos R Thuerlimann B J Aapro M 2008Eur J Cancer2008,44,6:1
9Clinical benefit in patients with metastatic bone disease : results of a phase 3 study of denosumab versus zoledronic acid显示文摘Vadhan-Raj S yon Moos R Fallowfield LJ 2012Ann Oncol2012,23,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费